Overview
Biotele
VirtualScopics makes medical imaging analysis tools that help clinical researchers speed up the drug development process. Its patented algorithms let researchers analyze data from computed tomography, MRI, PET, and ultrasound scans, with the aim of helping pharmaceutical, biotech, and medical device companies determine how an investigational drug is working (or not working). The firm also hopes its products can be used to develop diagnostic tools
...
Read More to help with disease treatment and surgery. VirtualScopics provides services for many large pharmaceutical companies, including GlaxoSmithKline and Johnson & Johnson; its largest customer is Pfizer. In 2016 BioTelemetry paid some $15.5 million to buy VirtualScopics.
Read Less
Read More to help with disease treatment and surgery. VirtualScopics provides services for many large pharmaceutical companies, including GlaxoSmithKline and Johnson & Johnson; its largest customer is Pfizer. In 2016 BioTelemetry paid some $15.5 million to buy VirtualScopics.
Read Less
Eric Converse
See more contacts
Computer Systems Design and Related Services
,
Professional, Scientific, and Technical Services
,
Computer software development and applications
Accounting, Tax Preparation, Bookkeeping, and Payroll Services
,
Advertising, Public Relations, and Related Services
,
Architectural, Engineering, and Related Services
,
Legal Services
,
Management, Scientific, and Technical Consulting Services
,
Other Professional, Scientific, and Technical Services
,
Scientific Research and Development Services
,
Specialized Design Services
?
?
?
Actual
?
Actual
#
Modelled
?
Contacts
Get in Touch with 5 Principals* and 28 Contacts
-
Eric ConverseChief Executive Officer and President
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Data
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.